Sophion Bioscience A/S

Danish producer of patch clamping devices reports on sales, marketing, growth

Published in Cardiovascular Business Week, June 28th, 2005

In the fall of 2004, Sophion Bioscience A/S launched the company's first products and by the end of this quarter, the company expects having completed customer installations in North America, Europe and Japan.

Together with other existing shareholders, NeuroSearch has completed an increase of Sophion's capital base of (Denmark kroner) DKK20 million (US$2.26 million). NeuroSearch has participated with DKK6.4 million (US$1.05 million) and thereby increased its ownership from 25% to 29%.

This strengthening of Sophion's capital base is to ensure the company's future growth and primarily be used for the up-scaling of the company's production of QPatch16...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cardiovascular Business Week

Source: Cardiovascular Business Week (2005-06-28)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry